Academic Health Science Network NENC DPS

Provision of market assessment support for innovation. This may include identification of options with recommendations as well as implementation and delivery: • Patent Searches; • Intellectual Property Filing, Renewals & ongoing management • Prior Art and freedom to operate searches; • Horizon scanning; • Market assessment; • Rapid evidence evaluation; • Literature review; • Commercialisation partners to support marketing; • Competitor analysis; • Market Size and usage; • Market segmentation and trends

Provision of specialist expertise to support the development of a value proposition. This may include delivery of the following: • Business model canvas development; • Business consultancy; • Specialist support for the development of business models; • Assessment of business options and opportunities in the health and life science; • Business processes; • Change management; • Forecasting and/or planning; • Organisational review; • Programme & project management; • Business Structure; • Business process re-engineering; • Social Value; • Peer or Key Opinion Leader Feedback (clinical expertise) Provision of prototype support for innovation. This may include identification of options with recommendations as well as implementation and delivery.

Provision of clinical trial and evidence generation support, such as real-world evaluation and health economics for an innovation. This may include identification of options with recommendations as well as implementation and delivery. • Support to develop protocols; • Support development of trial documentation e.g., Patient Information Sheets, informed consent forms etc. • Support for development and submission of documentation for ethics/HRA approval, such as IRAS forms (if required); • Support to develop strategy for site selection for trials & evaluations; • Support for NIHR portfolio adoption (Commercial, Non-commercial and Investigator Initiated Trials (IIT)); • Bid support to funders e.g., grant writing; • Project Management of Trials • Stakeholder engagement / • Systematic reviews • Care pathway analysis; • Health economics modelling including cost-effectiveness analysis and budget impact analysis; • Diagnostic test reference standard identification or development; • Analytical validity; • Diagnostic accuracy; • Clinical utility; • Cost and pricing modelling • Early Value Assessment (NICE) • Statistical Support Provision of regulatory approval support for innovation. This may include identification of options with recommendations as well as implementation and delivery.

Provision of commercialisation and scale-up support for innovation. This may include identification of options with recommendations as well as implementation and delivery: • Proof of Value development; • Growth and scale; • Internationalisation and trading globally; • Import and export; • Leadership and management including of individuals and teams; • Marketing including digital marketing; • Adoption and spread into the NHS market or healthcare markets world-wide; • Implementation Model • Business case Development in an NHS/Social Care setting; • Sales; • Manufacturing and outsourcing. • Procurement? • Supply chain expertise

Provision of corporate support to the AHSN for the delivery of its day-to-day business or extended support to innovators: • Marketing Support; • Comms Support; • Finance Support; • IT Support o Services; o Hardware; and o software • Health and Safety Services; • HR Support; • Organisational Development Support; • Development of software • Legal Services